Last reviewed · How we verify
Vactosertib and Durvalumab in Gastric Cancer
This trial will test the efficacy and safety of durvalumab in combination with vactosertib in patients with metastatic gastric cancers who failed ≥ 2 lines of chemotherapy
Details
| Lead sponsor | Hark Kyun Kim |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 55 |
| Start date | Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Stomach Neoplasm
Interventions
- durvalumab and vactosertib
Countries
South Korea